Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation
Authors
Keywords
-
Journal
Pathogens and Disease
Volume 77, Issue 3, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-04-26
DOI
10.1093/femspd/ftz026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zika vaccines and therapeutics: landscape analysis and challenges ahead
- (2018) Annelies Wilder-Smith et al. BMC Medicine
- Development of vaccines against Zika virus
- (2018) Gregory A Poland et al. LANCET INFECTIOUS DISEASES
- A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
- (2018) Viswanathan Ramasamy et al. PLoS Neglected Tropical Diseases
- Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
- (2018) Wanbo Tai et al. Emerging Microbes & Infections
- Prospects for a Zika Virus Vaccine
- (2017) Dan H. Barouch et al. IMMUNITY
- Evaluation of a Novel Reporter Virus Neutralization Test for Serological Diagnosis of Zika and Dengue Virus Infection
- (2017) Chao Shan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus
- (2017) Himanshu Garg et al. JOURNAL OF VIROLOGY
- An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design
- (2017) Akane Urakami et al. JOURNAL OF VIROLOGY
- Vaccine against Zika virus must remain a priority
- (2017) The Lancet Infectious Diseases LANCET INFECTIOUS DISEASES
- Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
- (2017) Susana V. Bardina et al. SCIENCE
- Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus
- (2017) Ming Yang et al. VACCINE
- Vaccination strategies against Zika virus
- (2017) Estefania Fernandez et al. Current Opinion in Virology
- Zika virus-like particle (VLP) based vaccine
- (2017) Hélène Boigard et al. PLoS Neglected Tropical Diseases
- A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients
- (2017) Chao Shan et al. EBioMedicine
- Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice
- (2017) Ming Yang et al. Scientific Reports
- Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies
- (2016) Niyati Khetarpal et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
- (2016) Ankur Poddar et al. BMC BIOTECHNOLOGY
- Structural Basis of Zika Virus-Specific Antibody Protection
- (2016) Haiyan Zhao et al. CELL
- Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody
- (2016) Lianpan Dai et al. Cell Host & Microbe
- Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes
- (2016) Alice Panchaud et al. CLINICAL MICROBIOLOGY REVIEWS
- Zika virus: a previously slow pandemic spreads rapidly through the Americas
- (2016) Derek Gatherer et al. JOURNAL OF GENERAL VIROLOGY
- Zika Virus–Induced Antibody Response Enhances Dengue Virus Serotype 2 Replication In Vitro
- (2016) Anna B. Kawiecki et al. JOURNAL OF INFECTIOUS DISEASES
- Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere
- (2016) Helen M. Lazear et al. JOURNAL OF VIROLOGY
- Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study
- (2016) Van-Mai Cao-Lormeau et al. LANCET
- Vaccine protection against Zika virus from Brazil
- (2016) Rafael A. Larocca et al. NATURE
- Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice
- (2016) Gopal Sapparapu et al. NATURE
- Immunogenic cross-talk between dengue and Zika viruses
- (2016) Stephen C Harrison NATURE IMMUNOLOGY
- Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
- (2016) Wanwisa Dejnirattisai et al. NATURE IMMUNOLOGY
- Assessing the global threat from Zika virus
- (2016) J. Lessler et al. SCIENCE
- Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection
- (2016) K. Stettler et al. SCIENCE
- Mapping global environmental suitability for Zika virus
- (2016) Jane P Messina et al. eLife
- Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses — Brazil, 2015
- (2016) Roosecelis Brasil Martines et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice
- (2015) Satoru Watanabe et al. JOURNAL OF VIROLOGY
- Zika virus: following the path of dengue and chikungunya?
- (2015) Didier Musso et al. LANCET
- Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
- (2015) Lav Tripathi et al. Frontiers in Microbiology
- Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production
- (2014) Mudassar Ahmad et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris
- (2013) Thomas Vogl et al. CURRENT OPINION IN BIOTECHNOLOGY
- Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
- (2013) Shailendra Mani et al. PLoS One
- Dengue-specific subviral nanoparticles: design, creation and characterization
- (2013) Niyati Khetarpal et al. JOURNAL OF NANOBIOTECHNOLOGY
- The History of Dengue Outbreaks in the Americas
- (2012) Olivia Brathwaite Dick et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Force of infection of dengue serotypes in a population-based study in the northeast of Brazil
- (2012) P. M. S. CASTANHA et al. EPIDEMIOLOGY AND INFECTION
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- (2010) Martina Beltramello et al. Cell Host & Microbe
- Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris
- (2010) Gaurav Batra et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil
- (2009) Cynthia Braga et al. ACTA TROPICA
- Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigen
- (2009) Chandrasekhar Gurramkonda et al. Microbial Cell Factories
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started